- Home
- STRO vs WHF Comparison
STRO vs WHF Comparison
Compare STRO & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | WHF |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.8M | 152.5M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | STRO | WHF |
|---|---|---|
| Price | $15.98 | $7.04 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 9 | 2 |
| Target Price | ★ $31.33 | $7.75 |
| AVG Volume (30 Days) | ★ 277.7K | 91.6K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 13.67% |
| EPS Growth | N/A | ★ 31.91 |
| EPS | N/A | ★ 0.44 |
| Revenue | ★ $38,419,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $6.07 |
| 52 Week High | $43.85 | $7.84 |
Technical Indicators
Market Signals| Indicator | STRO | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 32.12 | 47.64 |
| Support Level | $14.81 | $6.85 |
| Resistance Level | $17.33 | $7.22 |
| Average True Range (ATR) | 1.05 | 0.19 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 25.86 | 12.52 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.